IBDEI05N ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5395,1,3,0)
 ;;=3^Lichen Sclerosus et Atrophicus
 ;;^UTILITY(U,$J,358.3,5395,1,4,0)
 ;;=4^L90.0
 ;;^UTILITY(U,$J,358.3,5395,2)
 ;;=^70699
 ;;^UTILITY(U,$J,358.3,5396,0)
 ;;=L28.0^^32^352^5
 ;;^UTILITY(U,$J,358.3,5396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5396,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,5396,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,5396,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,5397,0)
 ;;=L66.1^^32^352^1
 ;;^UTILITY(U,$J,358.3,5397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5397,1,3,0)
 ;;=3^Lichen Planopilaris
 ;;^UTILITY(U,$J,358.3,5397,1,4,0)
 ;;=4^L66.1
 ;;^UTILITY(U,$J,358.3,5397,2)
 ;;=^5009253
 ;;^UTILITY(U,$J,358.3,5398,0)
 ;;=L43.0^^32^352^2
 ;;^UTILITY(U,$J,358.3,5398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5398,1,3,0)
 ;;=3^Lichen Planus,Hypertrophic
 ;;^UTILITY(U,$J,358.3,5398,1,4,0)
 ;;=4^L43.0
 ;;^UTILITY(U,$J,358.3,5398,2)
 ;;=^5009178
 ;;^UTILITY(U,$J,358.3,5399,0)
 ;;=L43.2^^32^352^6
 ;;^UTILITY(U,$J,358.3,5399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5399,1,3,0)
 ;;=3^Lichenoid Drug Reaction
 ;;^UTILITY(U,$J,358.3,5399,1,4,0)
 ;;=4^L43.2
 ;;^UTILITY(U,$J,358.3,5399,2)
 ;;=^5009180
 ;;^UTILITY(U,$J,358.3,5400,0)
 ;;=L43.9^^32^352^3
 ;;^UTILITY(U,$J,358.3,5400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5400,1,3,0)
 ;;=3^Lichen Planus,Unspec
 ;;^UTILITY(U,$J,358.3,5400,1,4,0)
 ;;=4^L43.9
 ;;^UTILITY(U,$J,358.3,5400,2)
 ;;=^5009183
 ;;^UTILITY(U,$J,358.3,5401,0)
 ;;=L93.0^^32^352^8
 ;;^UTILITY(U,$J,358.3,5401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5401,1,3,0)
 ;;=3^Lupus,Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,5401,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,5401,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,5402,0)
 ;;=L93.2^^32^352^10
 ;;^UTILITY(U,$J,358.3,5402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5402,1,3,0)
 ;;=3^Lupus,Erythematosus,Local
 ;;^UTILITY(U,$J,358.3,5402,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,5402,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,5403,0)
 ;;=L93.1^^32^352^11
 ;;^UTILITY(U,$J,358.3,5403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5403,1,3,0)
 ;;=3^Lupus,Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,5403,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,5403,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,5404,0)
 ;;=M32.0^^32^352^9
 ;;^UTILITY(U,$J,358.3,5404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5404,1,3,0)
 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
 ;;^UTILITY(U,$J,358.3,5404,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,5404,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,5405,0)
 ;;=M32.10^^32^352^12
 ;;^UTILITY(U,$J,358.3,5405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5405,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic
 ;;^UTILITY(U,$J,358.3,5405,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,5405,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,5406,0)
 ;;=M32.19^^32^352^14
 ;;^UTILITY(U,$J,358.3,5406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5406,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
 ;;^UTILITY(U,$J,358.3,5406,1,4,0)
 ;;=4^M32.19
 ;;^UTILITY(U,$J,358.3,5406,2)
 ;;=^5011759
 ;;^UTILITY(U,$J,358.3,5407,0)
 ;;=M32.9^^32^352^13
 ;;^UTILITY(U,$J,358.3,5407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5407,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
 ;;^UTILITY(U,$J,358.3,5407,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,5407,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,5408,0)
 ;;=E88.1^^32^352^7
 ;;^UTILITY(U,$J,358.3,5408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5408,1,3,0)
 ;;=3^Lipodystrophy NOS
 ;;^UTILITY(U,$J,358.3,5408,1,4,0)
 ;;=4^E88.1
 ;;^UTILITY(U,$J,358.3,5408,2)
 ;;=^5003028
 ;;^UTILITY(U,$J,358.3,5409,0)
 ;;=L60.1^^32^353^2
 ;;^UTILITY(U,$J,358.3,5409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5409,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,5409,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,5409,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,5410,0)
 ;;=L60.2^^32^353^1
 ;;^UTILITY(U,$J,358.3,5410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5410,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,5410,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,5410,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,5411,0)
 ;;=B35.1^^32^353^3
 ;;^UTILITY(U,$J,358.3,5411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5411,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,5411,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,5411,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,5412,0)
 ;;=L50.8^^32^354^4
 ;;^UTILITY(U,$J,358.3,5412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5412,1,3,0)
 ;;=3^Urticaria,Other Spec
 ;;^UTILITY(U,$J,358.3,5412,1,4,0)
 ;;=4^L50.8
 ;;^UTILITY(U,$J,358.3,5412,2)
 ;;=^5009203
 ;;^UTILITY(U,$J,358.3,5413,0)
 ;;=L50.0^^32^354^2
 ;;^UTILITY(U,$J,358.3,5413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5413,1,3,0)
 ;;=3^Urticaria,Allergic
 ;;^UTILITY(U,$J,358.3,5413,1,4,0)
 ;;=4^L50.0
 ;;^UTILITY(U,$J,358.3,5413,2)
 ;;=^5009200
 ;;^UTILITY(U,$J,358.3,5414,0)
 ;;=L50.6^^32^354^3
 ;;^UTILITY(U,$J,358.3,5414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5414,1,3,0)
 ;;=3^Urticaria,Contact
 ;;^UTILITY(U,$J,358.3,5414,1,4,0)
 ;;=4^L50.6
 ;;^UTILITY(U,$J,358.3,5414,2)
 ;;=^5009202
 ;;^UTILITY(U,$J,358.3,5415,0)
 ;;=L50.2^^32^354^1
 ;;^UTILITY(U,$J,358.3,5415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5415,1,3,0)
 ;;=3^Urticaria d/t Cold/Heat
 ;;^UTILITY(U,$J,358.3,5415,1,4,0)
 ;;=4^L50.2
 ;;^UTILITY(U,$J,358.3,5415,2)
 ;;=^271938
 ;;^UTILITY(U,$J,358.3,5416,0)
 ;;=L56.3^^32^354^5
 ;;^UTILITY(U,$J,358.3,5416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5416,1,3,0)
 ;;=3^Urticaria,Solar
 ;;^UTILITY(U,$J,358.3,5416,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,5416,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,5417,0)
 ;;=B02.8^^32^355^1
 ;;^UTILITY(U,$J,358.3,5417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5417,1,3,0)
 ;;=3^Zoster w/ Other Complications
 ;;^UTILITY(U,$J,358.3,5417,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,5417,2)
 ;;=^5000500
 ;;^UTILITY(U,$J,358.3,5418,0)
 ;;=B02.9^^32^355^2
 ;;^UTILITY(U,$J,358.3,5418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5418,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,5418,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,5418,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,5419,0)
 ;;=11000^^33^356^1^^^^1
 ;;^UTILITY(U,$J,358.3,5419,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5419,1,2,0)
 ;;=2^11000
 ;;^UTILITY(U,$J,358.3,5419,1,3,0)
 ;;=3^Debride ext eczematous skin,<10%
 ;;^UTILITY(U,$J,358.3,5420,0)
 ;;=11001^^33^356^2^^^^1
 ;;^UTILITY(U,$J,358.3,5420,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5420,1,2,0)
 ;;=2^11001
 ;;^UTILITY(U,$J,358.3,5420,1,3,0)
 ;;=3^Debride ext eczematous skin,Ea 10%
 ;;^UTILITY(U,$J,358.3,5421,0)
 ;;=11042^^33^356^3^^^^1
 ;;^UTILITY(U,$J,358.3,5421,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5421,1,2,0)
 ;;=2^11042
 ;;^UTILITY(U,$J,358.3,5421,1,3,0)
 ;;=3^Debride Subcut (epi/derm);20sq cm or <
 ;;^UTILITY(U,$J,358.3,5422,0)
 ;;=11045^^33^356^4^^^^1
 ;;^UTILITY(U,$J,358.3,5422,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5422,1,2,0)
 ;;=2^11045
 ;;^UTILITY(U,$J,358.3,5422,1,3,0)
 ;;=3^Debride Subcut (epi/derm);Ea Addl 20sq cm
 ;;^UTILITY(U,$J,358.3,5423,0)
 ;;=17000^^33^357^4^^^^1
 ;;^UTILITY(U,$J,358.3,5423,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5423,1,2,0)
 ;;=2^17000
 ;;^UTILITY(U,$J,358.3,5423,1,3,0)
 ;;=3^Destroy 1st Premalignant Lesion
 ;;^UTILITY(U,$J,358.3,5424,0)
 ;;=17004^^33^357^3^^^^1
 ;;^UTILITY(U,$J,358.3,5424,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5424,1,2,0)
 ;;=2^17004
 ;;^UTILITY(U,$J,358.3,5424,1,3,0)
 ;;=3^Destroy 15+ Premalignant Lesions
 ;;^UTILITY(U,$J,358.3,5425,0)
 ;;=17110^^33^357^1^^^^1
 ;;^UTILITY(U,$J,358.3,5425,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5425,1,2,0)
 ;;=2^17110
 ;;^UTILITY(U,$J,358.3,5425,1,3,0)
 ;;=3^Destroy 1-14 Benign Lesions
